Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training
Tania C. Sluckin(Vrije Universiteit Amsterdam), Maaike Corver, Manon N.G.J.A. Braat(Utrecht University), Shira H. de Bie(Amsterdam Neuroscience), Karin Horsthuis(Amsterdam University Medical Centers), Corrie A.M. Marijnen(Leiden University Medical Center), Henk Avenarius(Amsterdam Neuroscience), Jacobus W. A. Burger(Radboud University Nijmegen), Wernard A. A. Borstlap(Amsterdam University Medical Centers), Jennifer Bradshaw(Amsterdam Neuroscience), Evert-Jan G. Boerma(Zuyderland Medisch Centrum), W.T. van den Broek(St. Anna Hospital), Esther C. J. Consten(University Medical Center Groningen), Thijs A. Burghgraef(University Medical Center Groningen), Frank C. den Boer(Zaans Medisch Centrum), Anniek H. Boer(Amsterdam Neuroscience), Heleen M. D. Beekhuis(Amsterdam Neuroscience), Marjolein Ankersmit(Amsterdam University Medical Centers), Jaap Borstlap(Treant Zorggroep), Johanna E. Bouwman, Robert H. C. Bisschops(Amsterdam Neuroscience), Miranda Kusters(Radboud University Nijmegen), Willem A. Bemelman(Vrije Universiteit Amsterdam), Leonora S. F. Boogerd(Amsterdam Neuroscience), David W.G. ten Cate(Radboud University Nijmegen), Susanna M. van Aalten(Amsterdam Neuroscience), Sicco J. Braak(Amsterdam Neuroscience), Femke J. Amelung(Meander Medisch Centrum), Renée M. Barendse(Amsterdam UMC Location University of Amsterdam), Imogeen E. Antonisse(Erasmus MC), Jeltsje S. Cnossen(Amsterdam UMC Location University of Amsterdam), Ilsalien S. Bakker(University of Groningen), Tjeerd S. Aukema(Amsterdam Neuroscience), Pieter J. Tanis(Erasmus MC), Heleen M. Ceha(Amsterdam UMC Location University of Amsterdam), J. F. Ashruf(Amsterdam Neuroscience), Sanne-Marije J.A. Hazen(Vrije Universiteit Amsterdam), Geerard L. Beets(The Netherlands Cancer Institute), Frans C. H. Bakers(Maastricht University Medical Centre), Renu R. Bahadoer(Leiden University Medical Center), Fleur Bangert(Amsterdam Neuroscience), Maaike Berbée(Maastro Clinic), Arend G. J. Aalbers(The Netherlands Cancer Institute), Robert R.J. Coebergh van den Braak(Amsterdam Neuroscience), Liselotte W. van Bockel(Amsterdam Neuroscience), Vivian van Breest Smallenburg(Jeroen Bosch Ziekenhuis), Regina G. H. Beets‐Tan(Maastricht University), Sjirk W. van der Burg(Amsterdam Neuroscience), Amarins T. A. Brandsma(Amsterdam Neuroscience), Robin D. Blok(Amsterdam Neuroscience)
Cited by 6
Related Papers
Colorectal cancer
|The Lancet|2019|5k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k